5.連結財務諸表及び主な注記
(1)連結貸借対照表
|
|
|
|
|
|
|
|
|
|
|
|
(単位:百万円)
|
|
|
|
|
|
|
|
|
|
|
|
前連結会計年度
(2025年3月31日)
|
当連結会計年度
(2026年3月31日)
|
|
資産の部
|
|
|
|
|
流動資産
|
|
|
|
|
|
現金及び預金
|
102,655
|
116,695
|
|
|
|
受取手形及び売掛金
|
524,134
|
554,190
|
|
|
|
有価証券
|
38,927
|
24,976
|
|
|
|
商品及び製品
|
146,668
|
145,140
|
|
|
|
仕掛品
|
1,470
|
1,649
|
|
|
|
原材料及び貯蔵品
|
5,052
|
5,762
|
|
|
|
仕入割戻し等未収入金
|
17,647
|
19,892
|
|
|
|
その他
|
8,739
|
8,295
|
|
|
|
貸倒引当金
|
△1,197
|
△429
|
|
|
|
流動資産合計
|
844,099
|
876,172
|
|
|
固定資産
|
|
|
|
|
|
有形固定資産
|
|
|
|
|
|
|
建物及び構築物
|
153,096
|
155,869
|
|
|
|
|
|
減価償却累計額
|
△87,643
|
△90,597
|
|
|
|
|
|
建物及び構築物(純額)
|
65,453
|
65,271
|
|
|
|
|
機械装置及び運搬具
|
33,642
|
35,340
|
|
|
|
|
|
減価償却累計額
|
△21,010
|
△22,657
|
|
|
|
|
|
機械装置及び運搬具(純額)
|
12,631
|
12,683
|
|
|
|
|
工具、器具及び備品
|
19,617
|
20,301
|
|
|
|
|
|
減価償却累計額
|
△16,289
|
△16,688
|
|
|
|
|
|
工具、器具及び備品(純額)
|
3,328
|
3,612
|
|
|
|
|
土地
|
48,936
|
53,317
|
|
|
|
|
リース資産
|
2,959
|
2,949
|
|
|
|
|
|
減価償却累計額
|
△2,398
|
△2,406
|
|
|
|
|
|
リース資産(純額)
|
561
|
542
|
|
|
|
|
建設仮勘定
|
2,600
|
4,135
|
|
|
|
|
有形固定資産合計
|
133,512
|
139,563
|
|
|
|
無形固定資産
|
|
|
|
|
|
|
のれん
|
14
|
3,523
|
|
|
|
|
その他
|
12,094
|
12,150
|
|
|
|
|
無形固定資産合計
|
12,108
|
15,673
|
|
|
|
投資その他の資産
|
|
|
|
|
|
|
投資有価証券
|
84,399
|
79,212
|
|
|
|
|
繰延税金資産
|
2,683
|
2,549
|
|
|
|
|
退職給付に係る資産
|
20,048
|
25,215
|
|
|
|
|
その他
|
17,740
|
18,391
|
|
|
|
|
貸倒引当金
|
△760
|
△1,013
|
|
|
|
|
投資その他の資産合計
|
124,111
|
124,355
|
|
|
|
固定資産合計
|
269,732
|
279,593
|
|
|
資産合計
|
1,113,831
|
1,155,766
|
|
|
|
|
|
|
|
|
|
|
|
|
(単位:百万円)
|
|
|
|
|
|
|
|
|
|
|
|
前連結会計年度
(2025年3月31日)
|
当連結会計年度
(2026年3月31日)
|
|
負債の部
|
|
|
|
|
流動負債
|
|
|
|
|
|
支払手形及び買掛金
|
635,752
|
665,757
|
|
|
|
未払法人税等
|
9,949
|
10,001
|
|
|
|
賞与引当金
|
9,293
|
9,585
|
|
|
|
独占禁止法関連損失引当金
|
3,090
|
-
|
|
|
|
その他
|
21,028
|
27,707
|
|
|
|
流動負債合計
|
679,114
|
713,052
|
|
|
固定負債
|
|
|
|
|
|
繰延税金負債
|
17,413
|
17,915
|
|
|
|
再評価に係る繰延税金負債
|
1,178
|
1,175
|
|
|
|
退職給付に係る負債
|
2,186
|
2,142
|
|
|
|
その他
|
6,518
|
5,467
|
|
|
|
固定負債合計
|
27,296
|
26,701
|
|
|
負債合計
|
706,410
|
739,753
|
|
純資産の部
|
|
|
|
|
株主資本
|
|
|
|
|
|
資本金
|
13,546
|
13,546
|
|
|
|
資本剰余金
|
32,147
|
32,147
|
|
|
|
利益剰余金
|
332,375
|
363,582
|
|
|
|
自己株式
|
△499
|
△26,344
|
|
|
|
株主資本合計
|
377,569
|
382,932
|
|
|
その他の包括利益累計額
|
|
|
|
|
|
その他有価証券評価差額金
|
32,773
|
32,500
|
|
|
|
土地再評価差額金
|
△4,803
|
△4,809
|
|
|
|
為替換算調整勘定
|
2,365
|
2,736
|
|
|
|
退職給付に係る調整累計額
|
△613
|
2,516
|
|
|
|
その他の包括利益累計額合計
|
29,722
|
32,944
|
|
|
非支配株主持分
|
128
|
135
|
|
|
純資産合計
|
407,420
|
416,012
|
|
負債純資産合計
|
1,113,831
|
1,155,766
|
E02780
99870
株式会社スズケン
SUZUKEN CO.,LTD.
通期第1号参考様式 [日本基準](連結)
Japan GAAP
true
cte
cte
2025-04-01
2026-03-31
FY
2026-03-31
2024-04-01
2025-03-31
2025-03-31
1
false
false
false
99870
2026-05-14
99870
2025-04-01
2026-03-31
99870
2025-04-01
2026-03-31
jppfs_cor:CapitalStockMember
99870
2025-04-01
2026-03-31
jppfs_cor:CapitalSurplusMember
99870
2025-04-01
2026-03-31
jppfs_cor:ForeignCurrencyTranslationAdjustmentMember
99870
2025-04-01
2026-03-31
jppfs_cor:NonControllingInterestsMember
99870
2025-04-01
2026-03-31
jppfs_cor:RemeasurementsOfDefinedBenefitPlansMember
99870
2025-04-01
2026-03-31
jppfs_cor:RetainedEarningsMember
99870
2025-04-01
2026-03-31
jppfs_cor:RevaluationReserveForLandMember
99870
2025-04-01
2026-03-31
jppfs_cor:ShareholdersEquityMember
99870
2025-04-01
2026-03-31
jpcrp_cor:TotalOfReportableSegmentsAndOthersMember
99870
2025-04-01
2026-03-31
jppfs_cor:TreasuryStockMember
99870
2025-04-01
2026-03-31
tse-acedjpfr-99870:TheCommunityHealthcareAndNursingCareSupportBusinessReportableSegmentMember
99870
2025-04-01
2026-03-31
tse-acedjpfr-99870:TheHealthcareProductDevelopmentBusinessReportableSegmentMember
99870
2025-04-01
2026-03-31
tse-acedjpfr-99870:TheHealthcareRelatedServicesBusinessReportableSegmentsMember
99870
2025-04-01
2026-03-31
tse-acedjpfr-99870:ThePharmaceuticalDistributionBusinessReportableSegmentsMember
99870
2025-04-01
2026-03-31
tse-acedjpfr-99870:TheSpecialtyDrugContractDistributionBusinessReportableSegmentMember
99870
2025-04-01
2026-03-31
jpcrp_cor:UnallocatedAmountsAndEliminationMember
99870
2025-04-01
2026-03-31
jppfs_cor:ValuationAndTranslationAdjustmentsMember
99870
2025-04-01
2026-03-31
jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember
99870
2026-03-31
99870
2026-03-31
jppfs_cor:CapitalStockMember
99870
2026-03-31
jppfs_cor:CapitalSurplusMember
99870
2026-03-31
jppfs_cor:ForeignCurrencyTranslationAdjustmentMember
99870
2026-03-31
jppfs_cor:NonControllingInterestsMember
99870
2026-03-31
jppfs_cor:RemeasurementsOfDefinedBenefitPlansMember
99870
2026-03-31
jppfs_cor:RetainedEarningsMember
99870
2026-03-31
jppfs_cor:RevaluationReserveForLandMember
99870
2026-03-31
jppfs_cor:ShareholdersEquityMember
99870
2026-03-31
jpcrp_cor:TotalOfReportableSegmentsAndOthersMember
99870
2026-03-31
jppfs_cor:TreasuryStockMember
99870
2026-03-31
tse-acedjpfr-99870:TheCommunityHealthcareAndNursingCareSupportBusinessReportableSegmentMember
99870
2026-03-31
tse-acedjpfr-99870:TheHealthcareProductDevelopmentBusinessReportableSegmentMember
99870
2026-03-31
tse-acedjpfr-99870:TheHealthcareRelatedServicesBusinessReportableSegmentsMember
99870
2026-03-31
tse-acedjpfr-99870:ThePharmaceuticalDistributionBusinessReportableSegmentsMember
99870
2026-03-31
tse-acedjpfr-99870:TheSpecialtyDrugContractDistributionBusinessReportableSegmentMember
99870
2026-03-31
jpcrp_cor:UnallocatedAmountsAndEliminationMember
99870
2026-03-31
jppfs_cor:ValuationAndTranslationAdjustmentsMember
99870
2026-03-31
jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember
99870
2024-04-01
2025-03-31
99870
2024-04-01
2025-03-31
jppfs_cor:CapitalStockMember
99870
2024-04-01
2025-03-31
jppfs_cor:CapitalSurplusMember
99870
2024-04-01
2025-03-31
jppfs_cor:ForeignCurrencyTranslationAdjustmentMember
99870
2024-04-01
2025-03-31
jppfs_cor:NonControllingInterestsMember
99870
2024-04-01
2025-03-31
jppfs_cor:RemeasurementsOfDefinedBenefitPlansMember
99870
2024-04-01
2025-03-31
jppfs_cor:RetainedEarningsMember
99870
2024-04-01
2025-03-31
jppfs_cor:RevaluationReserveForLandMember
99870
2024-04-01
2025-03-31
jppfs_cor:ShareholdersEquityMember
99870
2024-04-01
2025-03-31
jpcrp_cor:TotalOfReportableSegmentsAndOthersMember
99870
2024-04-01
2025-03-31
jppfs_cor:TreasuryStockMember
99870
2024-04-01
2025-03-31
tse-acedjpfr-99870:TheCommunityHealthcareAndNursingCareSupportBusinessReportableSegmentMember
99870
2024-04-01
2025-03-31
tse-acedjpfr-99870:TheHealthcareProductDevelopmentBusinessReportableSegmentMember
99870
2024-04-01
2025-03-31
tse-acedjpfr-99870:TheHealthcareRelatedServicesBusinessReportableSegmentsMember
99870
2024-04-01
2025-03-31
tse-acedjpfr-99870:ThePharmaceuticalDistributionBusinessReportableSegmentsMember
99870
2024-04-01
2025-03-31
tse-acedjpfr-99870:TheSpecialtyDrugContractDistributionBusinessReportableSegmentMember
99870
2024-04-01
2025-03-31
jpcrp_cor:UnallocatedAmountsAndEliminationMember
99870
2024-04-01
2025-03-31
jppfs_cor:ValuationAndTranslationAdjustmentsMember
99870
2024-04-01
2025-03-31
jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember
99870
2025-03-31
99870
2025-03-31
jppfs_cor:CapitalStockMember
99870
2025-03-31
jppfs_cor:CapitalSurplusMember
99870
2025-03-31
jppfs_cor:ForeignCurrencyTranslationAdjustmentMember
99870
2025-03-31
jppfs_cor:NonControllingInterestsMember
99870
2025-03-31
jppfs_cor:RemeasurementsOfDefinedBenefitPlansMember
99870
2025-03-31
jppfs_cor:RetainedEarningsMember
99870
2025-03-31
jppfs_cor:RevaluationReserveForLandMember
99870
2025-03-31
jppfs_cor:ShareholdersEquityMember
99870
2025-03-31
jpcrp_cor:TotalOfReportableSegmentsAndOthersMember
99870
2025-03-31
jppfs_cor:TreasuryStockMember
99870
2025-03-31
tse-acedjpfr-99870:TheCommunityHealthcareAndNursingCareSupportBusinessReportableSegmentMember
99870
2025-03-31
tse-acedjpfr-99870:TheHealthcareProductDevelopmentBusinessReportableSegmentMember
99870
2025-03-31
tse-acedjpfr-99870:TheHealthcareRelatedServicesBusinessReportableSegmentsMember
99870
2025-03-31
tse-acedjpfr-99870:ThePharmaceuticalDistributionBusinessReportableSegmentsMember
99870
2025-03-31
tse-acedjpfr-99870:TheSpecialtyDrugContractDistributionBusinessReportableSegmentMember
99870
2025-03-31
jpcrp_cor:UnallocatedAmountsAndEliminationMember
99870
2025-03-31
jppfs_cor:ValuationAndTranslationAdjustmentsMember
99870
2025-03-31
jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember
99870
2024-03-31
99870
2024-03-31
jppfs_cor:CapitalStockMember
99870
2024-03-31
jppfs_cor:CapitalSurplusMember
99870
2024-03-31
jppfs_cor:ForeignCurrencyTranslationAdjustmentMember
99870
2024-03-31
jppfs_cor:NonControllingInterestsMember
99870
2024-03-31
jppfs_cor:RemeasurementsOfDefinedBenefitPlansMember
99870
2024-03-31
jppfs_cor:RetainedEarningsMember
99870
2024-03-31
jppfs_cor:RevaluationReserveForLandMember
99870
2024-03-31
jppfs_cor:ShareholdersEquityMember
99870
2024-03-31
jppfs_cor:TreasuryStockMember
99870
2024-03-31
jppfs_cor:ValuationAndTranslationAdjustmentsMember
99870
2024-03-31
jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember
iso4217:JPY
xbrli:pure